Featured Research

from universities, journals, and other organizations

Genetic Selection Of Target Stem Cell Populations

Date:
December 2, 2007
Source:
University of Nottingham
Summary:
Human embryonic stem cells can be genetically manipulated to help select out desirable cell types, according to a new study. This advance could help scientists develop better ways of deriving useful cell populations for therapeutic and research purposes. Although human embryonic stem cells can theoretically become any kind of cell in the body, directing this differentiation and selecting for a particular cell type is challenging.

Human embryonic stem cells can be genetically manipulated to help select out desirable cell types, according to a University of Nottingham study published online in Molecular Therapy.

This advance could help scientists develop better ways of deriving useful cell populations for therapeutic and research purposes.

Although human embryonic stem cells (hESCs) can theoretically become any kind of cell in the body, directing this differentiation and selecting for a particular cell type is challenging.

Dr Chris Denning and his team at The University of Nottingham manipulated certain genetic targets in their stem cells to enhance the selection of heart muscle cells from other cell types present in their culture.

They increased the percentage of heart muscle cells present to as much as ninety-one percent by selecting out fast dividing cells and selecting for cells that expressed genes characteristic of these slower dividing cardiac cells.

According to the authors, this strategy could be easily manipulated to select for other cell types. This paper is one of the first to document the successful selection of one kind of cell in hESCs — an important step towards realizing their potential.

Dr Denning, of the Wolfson Centre for Stem Cells, Tissue Engineering and Modelling (STEM) at The University of Nottingham, said: “Human embryonic stem cells are remarkable because we can keep them at a primitive stage of development for a long time in the laboratory, and yet by changing their environment we can also coax them into becoming virtually any cell type within the human body.

“This includes beating heart cells, also known as cardiomyocytes. In the longer term, cardiomyocytes could be used for testing the safety of new pharmaceutical products or for transplanting into patients hearts after heart attack. The trouble is that these uses will require pure populations of cardiomyocytes but until now whenever we have produced cardiomyocytes, we have also produced many other unwanted 'contaminating' cell types such as brain cells or liver cells.

“What we describe in the present research is a method to eliminate the unwanted cells and produce almost pure populations of cardiomyocytes.

“There is still a lot of work to be done, but this really does provide a first step towards being able to use cardiomyocytes derived from human embryonic stem cells for important clinical applications.”


Story Source:

The above story is based on materials provided by University of Nottingham. Note: Materials may be edited for content and length.


Cite This Page:

University of Nottingham. "Genetic Selection Of Target Stem Cell Populations." ScienceDaily. ScienceDaily, 2 December 2007. <www.sciencedaily.com/releases/2007/11/071130224755.htm>.
University of Nottingham. (2007, December 2). Genetic Selection Of Target Stem Cell Populations. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2007/11/071130224755.htm
University of Nottingham. "Genetic Selection Of Target Stem Cell Populations." ScienceDaily. www.sciencedaily.com/releases/2007/11/071130224755.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins